Ocrelizumab-ocsq 920 mg / hyaluronidase-ocsq 23,000 UNT in 23 mL Injection
RxNorm 2693458 NDC Crossover

The following National Drug Codes (NDCs) are directly associated with the clinical concept for Ocrelizumab-ocsq 920 mg / hyaluronidase-ocsq 23,000 UNT in 23 mL Injection (RxCUI 2693458). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.

Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.